SEC Form 4 · accession 0001553878-15-000008
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis A Ausiello
Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 6, 2015 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2015 | M | 706 | $63.86 | A | 13,871 | D | |
| Common Stock | Mar 5, 2015 | S | 706 | $115.00 | D | 13,165 | D | |
| Common StockF2 | holding | — | — | — | 3,500 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $63.86 | Mar 5, 2015 | M | 706 | D | — | Jan 2, 2024 | Common Stock | 706 | 2,117 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2014.
- F2The shares of ALNY common stock are held in a trust, of which the reporting person's spouse is the trustee.
- F3The stock option vests as to 25% on 3/31/2014 and as to an additional 25% of the shares granted at the end of each subsequent quarter.